Literature DB >> 11270424

Possible implications of arginase and diamine oxidase in prostatic carcinoma.

A Keskinege1, S Elgün, E Yilmaz.   

Abstract

Polyamine metabolism in prostatic tissue, which may give rise to prostatic hyperplasia by inducing cell proliferation, is controlled primarily by two enzymes: arginase and diamine oxidase (DAO). Arginase catalyzes the synthesis of ornithine, the precursor for polyamines from arginine, whereas DAO catalyzes the oxidation of diamines. such as spermine and spermidine, to a much less active compound called putrescine. In this study, we evaluated arginase and DAO activities in prostate tissues of 50 patients with benign prostatic hyperplasia and in 23 patients with prostatic carcinoma. Both DAO and arginase activities were found to be elevated in cancer tissues as compared to benign prostatic hyperplasia (fivefold and twofold, respectively; P < .001). A strong inverse correlation between arginase and DAO activities was observed in those in the cancer group (r = -0.65; P < .001). Gleason grades of prostatic carcinomas were well correlated with both arginase and DAO activities. Results suggest that DAO and arginase might play an essential role in the mechanism of prostatic disease process by modulating polyamine levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11270424

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  5 in total

1.  Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis.

Authors:  Wenjun Cao; Bill Sun; Mark A Feitelson; Tong Wu; Ran Tur-Kaspa; Qishi Fan
Journal:  Int J Cancer       Date:  2009-06-15       Impact factor: 7.396

2.  Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.

Authors:  Philippe O Gannon; Jessica Godin-Ethier; Matthew Hassler; Nathalie Delvoye; Meghan Aversa; Alexis O Poisson; Benjamin Péant; Mona Alam Fahmy; Fred Saad; Réjean Lapointe; Anne-Marie Mes-Masson
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

3.  Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

Authors:  Vincenzo Bronte; Tihana Kasic; Giorgia Gri; Keti Gallana; Giovanna Borsellino; Ilaria Marigo; Luca Battistini; Massimo Iafrate; Tommaso Prayer-Galetti; Francesco Pagano; Antonella Viola
Journal:  J Exp Med       Date:  2005-04-11       Impact factor: 14.307

4.  Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB.

Authors:  Bo-Ram Jin; Hyo-Jin An
Journal:  Aging (Albany NY)       Date:  2021-08-19       Impact factor: 5.682

5.  Biochemical Markers of Saliva in Lung Cancer: Diagnostic and Prognostic Perspectives.

Authors:  Lyudmila V Bel'skaya; Elena A Sarf; Victor K Kosenok; Ivan A Gundyrev
Journal:  Diagnostics (Basel)       Date:  2020-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.